Stable Pharmaceutical Formulation for oral administration comprising levocetirizine or one of its Salts are acceptable from the standpoint of Pharmacist, and montelukast or one of its Salts are acceptable from the standpoint of pharmacist

摘要

This relates to a Pharmaceutical Formulation for oral administration to prevent or treat allergic rhinitis or Asthma.Comprising: (a) a first part comprising particles (or one of its Salts are acceptable from the point of view of pharmaceutical and organic acid; and (b) a second part of particles comprising montelukast or one of its Salts are acceptable from the standpoint farmacu00e9 Products.Pharmaceutical formulation according to the present comprises an organic acid as Stabilizing Agent, which can effectively inhibit the production of levocetirizine and related substances with montelukast, and thus show good stability.